亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢楷倫公司銷售部  

埃索美拉唑,埃索美拉唑鎂三水合物,5-甲氧基-2-巰基-1H-苯并咪唑,頭孢雷特,普格拉雷等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:童瑤
  • 電話:027-88395717
  • 郵件:kailun002@126.com
  • 傳真:027-88735683
  • QQ:2524490512
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 3543-73-5禁發 鹽酸苯達莫司汀中間體的廠家
3543-73-5禁發 鹽酸苯達莫司汀中間體的廠家
單價 111.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 1kg起訂11kg
品牌 3543-73-5
型號 3543-73-5
規格 3543-73-5
過期 長期有效
更新 2013-09-26 11:11
 
詳細信息
產品名稱: 5-氨基-1-甲基-1H-苯并咪唑-2-丁酸乙酯 
3543-73-5禁發 鹽酸苯達莫司汀中間體的廠家
英文名稱: 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester 
Cas No.: 3543-73-5 
結構式:  
3543-73-5是禁發 鹽酸苯達莫司汀中間體

產品名稱: 5-氨基-1-甲基-1H-苯并咪唑-2-丁酸乙酯 
3543-73-5禁發 鹽酸苯達莫司汀中間體的廠家
英文名稱: 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester 
Cas No.: 3543-73-5 
結構式:  
3543-73-5是禁發 鹽酸苯達莫司汀中間體

©2025 武漢楷倫公司銷售部 版權所有   技術支持:化工網   訪問量:10678  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |